CLPTM1L and ovarian carcinoma: Cleft lip and palate transmembrane 1-like (CLPTM1L), also called cisplatin resistance-related gene 9 (CRR9), is a 62 kDa protein of 538 amino acids that was identified among the genes involved in resistance to the anticancer drug cisplatin in ovarian cancer cells [11].